Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.

Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K, Petralia F, Li Y, Liang WW, Reva B, Krek A, Ji J, Song X, Liu W, Hong R, Yao L, Blumenberg L, Savage SR, Wendl MC, Wen B, Li K, Tang LC, MacMullan MA, Avanessian SC, Kane MH, Newton CJ, Cornwell M, Kothadia RB, Ma W, Yoo S, Mannan R, Vats P, Kumar-Sinha C, Kawaler EA, Omelchenko T, Colaprico A, Geffen Y, Maruvka YE, da Veiga Leprevost F, Wiznerowicz M, Gümüş ZH, Veluswamy RR, Hostetter G, Heiman DI, Wyczalkowski MA, Hiltke T, Mesri M, Kinsinger CR, Boja ES, Omenn GS, Chinnaiyan AM, Rodriguez H, Li QK, Jewell SD, Thiagarajan M, Getz G, Zhang B, Fenyö D, Ruggles KV, Cieslik MP, Robles AI, Clauser KR, Govindan R, Wang P, Nesvizhskii AI, Ding L, Mani DR, Carr SA, Clinical Proteomic Tumor Analysis Consortium

Open source

DOI
10.1016/j.cell.2020.06.013
Published
2020 Jul 9
Container
Cell
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cell.2020.06.013,
  title = {Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.},
  author = {Gillette MA and Satpathy S and Cao S and Dhanasekaran SM and Vasaikar SV and Krug K and Petralia F and Li Y and Liang WW and Reva B and Krek A and Ji J and Song X and Liu W and Hong R and Yao L and Blumenberg L and Savage SR and Wendl MC and Wen B and Li K and Tang LC and MacMullan MA and Avanessian SC and Kane MH and Newton CJ and Cornwell M and Kothadia RB and Ma W and Yoo S and Mannan R and Vats P and Kumar-Sinha C and Kawaler EA and Omelchenko T and Colaprico A and Geffen Y and Maruvka YE and da Veiga Leprevost F and Wiznerowicz M and Gümüş ZH and Veluswamy RR and Hostetter G and Heiman DI and Wyczalkowski MA and Hiltke T and Mesri M and Kinsinger CR and Boja ES and Omenn GS and Chinnaiyan AM and Rodriguez H and Li QK and Jewell SD and Thiagarajan M and Getz G and Zhang B and Fenyö D and Ruggles KV and Cieslik MP and Robles AI and Clauser KR and Govindan R and Wang P and Nesvizhskii AI and Ding L and Mani DR and Carr SA and Clinical Proteomic Tumor Analysis Consortium},
  year = {2020},
  journal = {Cell},
  doi = {10.1016/j.cell.2020.06.013},
  url = {https://doi.org/10.1016/j.cell.2020.06.013}
}

RIS

TY  - JOUR
TI  - Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
AU  - Gillette MA
AU  - Satpathy S
AU  - Cao S
AU  - Dhanasekaran SM
AU  - Vasaikar SV
AU  - Krug K
AU  - Petralia F
AU  - Li Y
AU  - Liang WW
AU  - Reva B
AU  - Krek A
AU  - Ji J
AU  - Song X
AU  - Liu W
AU  - Hong R
AU  - Yao L
AU  - Blumenberg L
AU  - Savage SR
AU  - Wendl MC
AU  - Wen B
AU  - Li K
AU  - Tang LC
AU  - MacMullan MA
AU  - Avanessian SC
AU  - Kane MH
AU  - Newton CJ
AU  - Cornwell M
AU  - Kothadia RB
AU  - Ma W
AU  - Yoo S
AU  - Mannan R
AU  - Vats P
AU  - Kumar-Sinha C
AU  - Kawaler EA
AU  - Omelchenko T
AU  - Colaprico A
AU  - Geffen Y
AU  - Maruvka YE
AU  - da Veiga Leprevost F
AU  - Wiznerowicz M
AU  - Gümüş ZH
AU  - Veluswamy RR
AU  - Hostetter G
AU  - Heiman DI
AU  - Wyczalkowski MA
AU  - Hiltke T
AU  - Mesri M
AU  - Kinsinger CR
AU  - Boja ES
AU  - Omenn GS
AU  - Chinnaiyan AM
AU  - Rodriguez H
AU  - Li QK
AU  - Jewell SD
AU  - Thiagarajan M
AU  - Getz G
AU  - Zhang B
AU  - Fenyö D
AU  - Ruggles KV
AU  - Cieslik MP
AU  - Robles AI
AU  - Clauser KR
AU  - Govindan R
AU  - Wang P
AU  - Nesvizhskii AI
AU  - Ding L
AU  - Mani DR
AU  - Carr SA
AU  - Clinical Proteomic Tumor Analysis Consortium
PY  - 2020
JO  - Cell
DO  - 10.1016/j.cell.2020.06.013
UR  - https://doi.org/10.1016/j.cell.2020.06.013
ER  -

APA

MA, G., S, S., S, C., SM, D., SV, V., K, K., F, P., Y, L., WW, L., B, R., A, K., J, J., X, S., W, L., R, H., L, Y., L, B., SR, S., MC, W., B, W., K, L., LC, T., MA, M., SC, A., MH, K., CJ, N., M, C., RB, K., W, M., S, Y., R, M., P, V., C, K., EA, K., T, O., A, C., Y, G., YE, M., F, D. V. L., M, W., ZH, G., RR, V., G, H., DI, H., MA, W., T, H., M, M., CR, K., ES, B., GS, O., AM, C., H, R., QK, L., SD, J., M, T., G, G., B, Z., D, F., KV, R., MP, C., AI, R., KR, C., R, G., P, W., AI, N., L, D., DR, M., SA, C., & Consortium, C. P. T. A. (2020). Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.. Cell. https://doi.org/10.1016/j.cell.2020.06.013

Source records